Gene · 84959
Papers1,799
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,799
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Significance of platelet adhesion-related genes in colon cancer based on non-negative matrix factorization-based clustering algorithm. | Digit Health | 2023 | 37766908 | PubTator, text mining | PubMed |
| Therapeutic Implications of Renin-Angiotensin System Modulators in Alzheimer's Dementia. | Pharmaceutics | 2023 | 37765259 | PubTator, text mining | PubMed |
| Increased microglia activation in late non-central nervous system cancer survivors links to chronic systemic symptomatology. | Hum Brain Mapp | 2023 | 37751068 | PubTator, text mining | PubMed |
| Identification of novel first-trimester serum biomarkers for early prediction of preeclampsia. | J Transl Med | 2023 | 37718445 | PubTator, text mining | PubMed |
| Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitors. | Cancer Med | 2023 | 37712645 | PubTator, text mining | PubMed |
| Variability of Replicates of Intraocular Inflammatory Biomarkers in Ocular Fluid Samples Analyzed with Multiplex Assays. | Clin Ophthalmol | 2023 | 37705679 | PubTator, text mining | PubMed |
| The Prognosis-Predictive and Immunoregulatory Role of SUMOylation Related Genes: Potential Novel Targets in Prostate Cancer Treatment. | Int J Mol Sci | 2023 | 37686409 | PubTator, text mining | PubMed |
| Application of Novel Transcription Factor Machine Learning Model and Targeted Drug Combination Therapy Strategy in Triple Negative Breast Cancer. | Int J Mol Sci | 2023 | 37686305 | PubTator, text mining | PubMed |
| Macrophage-Derived Chemokine MDC/CCL22: An Ambiguous Finding in COVID-19. | Int J Mol Sci | 2023 | 37685890 | PubTator, text mining | PubMed |
| Identification of Characteristic Genes and Immune Cell Infiltration Signatures in Chronic Obstructive Pulmonary Disease. | Altern Ther Health Med | 2023 | 37678858 | PubTator, text mining | PubMed |
| Evaluation of serum cytokines and acute phase proteins as possible pharmacodynamic biomarkers to monitor endoscopic remission during ustekinumab therapy in patients with Crohn's disease. | Ther Adv Gastroenterol | 2023 | 37655059 | PubTator, text mining | PubMed |
| Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance. | Nat Commun | 2023 | 37644036 | PubTator, text mining | PubMed |
| A Systematic Compilation of Human SH3 Domains: A Versatile Superfamily in Cellular Signaling. | Cells | 2023 | 37626864 | PubTator, text mining | PubMed |
| Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas. | Blood | 2023 | 37623434 | PubTator, text mining | PubMed |
| Post-translational modifications and immune responses in liver cancer. | Front Immunol | 2023 | 37609076 | PubTator, text mining | PubMed |
| Depletion of soluble cytokines unlocks the immunomodulatory bioactivity of extracellular vesicles. | J Extracell Vesicles | 2023 | 37548263 | PubTator, text mining | PubMed |
| The effect of silver nanoparticles on learning and memory in rodents: "a systematic review". | J Occup Med Toxicol | 2023 | 37525184 | PubTator, text mining | PubMed |
| Quantitative multiorgan proteomics of fatal COVID-19 uncovers tissue-specific effects beyond inflammation. | EMBO Mol Med | 2023 | 37519267 | PubTator, text mining | PubMed |
| Interplay of Oxidative Stress, Inflammation, and Autophagy in RAW 264.7 Murine Macrophage Cell Line Challenged with Si/SiO2 Quantum Dots. | Materials (Basel) | 2023 | 37512357 | PubTator, text mining | PubMed |
| The Multiple Faces of the MRN Complex: Roles in Medulloblastoma and Beyond. | Cancers (Basel) | 2023 | 37509263 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84959/papers?page=5